ISLR

From Wikipedia, the free encyclopedia

ISLR
Identifiers
AliasesISLR, HsT17563, Meflin, immunoglobulin superfamily containing leucine-rich repeat, immunoglobulin superfamily containing leucine rich repeat
External IDsOMIM: 602059 MGI: 1349645 HomoloGene: 4050 GeneCards: ISLR
Orthologs
SpeciesHumanMouse
Entrez

3671

26968

Ensembl

ENSG00000129009
ENSG00000288508

ENSMUSG00000037206

UniProt

O14498

Q6GU68

RefSeq (mRNA)

NM_201526
NM_005545

NM_001195431
NM_012043

RefSeq (protein)

NP_005536
NP_958934

NP_001182360
NP_036173

Location (UCSC)Chr 15: 74.17 – 74.18 MbChr 9: 58.06 – 58.11 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse
Figure 1. Predicted Protein ISLR Tertiary Structure by i-TASSER Estimated TM-Score = 0.47±0.15 Estimated RMSD = 11.8±4.5Å

In humans, the immunoglobulin super family containing leucine-rich repeat (ISLR) protein is encoded by the ISLR gene.[5] Current RNA-seq studies show that the protein is highly expressed in the endometrium and ovary and shows expression among 25 other tissues.[6] The protein is seen localized in the cytoplasm,[7] plasma membrane,[8] extracellular exosome,[9] and platelet alpha granule lumen.[5] Furthermore, the protein is known to play a role in platelet degranulation,[5] cell adhesion,[10] and response to elevated platelet cytosolic Ca2+.[11]

Gene[edit]

The aliases for ISLR are Meflin, HsT17563, and mesenchymal stromal-cell and fibroblast-expressing Linx paralogue.[5] The gene is part of the I-set family.[5]

The most updated annotation shows the gene spanning from 74,173,710 to 74,176,871 base pairs (3,161 bp) with location on the plus strand at position 15q24.1 (Chromosome 15).[5] The gene contains 3 exons and 4 distinct introns.[5][12]

Transcription[edit]

Known isoforms[edit]

The ISLR gene have two known transcript isoforms on the plus strands: ISLR transcript variant 1[13] and ISLR transcript variant 2.[14] Both variants encode for the same protein.[15]

Transcript variant 1 encodes for the longest protein isoform with the length of 2,331 bp, containing 2 exons.[13]

Transcript variant 2 encodes for the shorter protein isoform with the length of 2,128 bp, containing 2 exons.[14] This variant differs in the 5' UTR compared to variant 1.[14]

Protein[edit]

Physical features[edit]

The human gene of ISLR has two alternatively spliced identical isoforms.[11] The domains of the ISLR gene follows as: LRR_8 (leucine-rich repeat), LRR_RI (ribonuclease inhibitor), PCC (polycystin cation channel protein) Super family, and Ig (immunoglobulin).[16]

The predicted isoelectric point of unmodified protein ISLR is 5.3.[12] The calculated molar mass is 46.0 kDa.[10]

The ISLR protein has 428 amino acids (aa) in humans.[17] Through the Statistical Analysis of Protein Sequences (SAPS) tool, the percentage of most amino acid residues is about its average percentage among human proteins except leucine which shows high abundance compared to a normal protein.[18] This is expected with the gene containing multiple LRR (leucine-rich repeats) structural motifs.[5] There is a significantly low abundance of methionine (predicted to be 0.5%).[18] In summary, the positively charged amino acid residues overcounts the negatively charged amino acid residues.[18]

Figure 2. Phobius Prediction of Signal Peptide and Transmembrane Domain

Through SAPS tool, there are two predicted identical four-block length repetitive structures that fall within LRR structural motifs: LSHL at 97-100 bp and 172-175 bp.[18]

One high-scoring transmembrane segment was predicted through the SAPS tool from 411 to 428 aa (length 18) with a pocket from 417 to 418 aa.[18] The Phobius prediction for the ISLR protein sequence illustrated the potential transmembrane domain and a signal peptide (Figure 2).[19] The SignalP-5.0 prediction for the signal peptide reported a likelihood of 0.9989 with a cleavage site between position 18 and 19 with the probability of 0.9146.[20]

Post-translational modifications[edit]

Phosphorylation Sites

There are 31 predicted phosphorylation sites in the protein sequence for ISLR in humans from NetPhos.[21] The results were filtered for best predictions for each residue display and accounted for serine, threonine, and tyrosine.

Through Eukaryotic Structural Motif (ELM tool) predictions, eight distinct phosphorylation sites were identified for the protein:[22]

  1. Glycogen synthase kinase-3 (GSK3)[23] phosphorylation site at position 234-241 aa.
  2. Phosphatidylinositol 3-kinase related kinase (PIKK) phosphorylation site[24] at position 238-244 aa.
  3. Casein kinase (CK1) phosphorylation site[25] at position 335-341 aa.
  4. Two CK2 phosphorylation sites[26] at positions 343-349 aa and 376-382 aa.
  5. Proline-Directed (MAPK) phosphorylation site[27] at position 343-349 aa.
  6. Polo-like kinase phosphosites 1 (Plk1) at positions 336-342 aa and 351-357 aa. Ser/Thr residues are phosphorylated by the kinase.[28]
  7. Plk4 phosphosite at position 415-421 aa. Ser/Thr residues are phosphorylated by the kinase.[29]
  8. Two NEK2 phosphorylation sites[30] at positions 415-420 bp and 423-428 aa.
Post-Translational Modifications predicted by Eukaryotic Structural Motif (ELM) Prediction in human ISLR protein
Name Position (aa) Cell Compartment(s)
N-degron[31] 1-3 Cytosol
Endosome-Lysosome-Basolateral sorting signals[32] 2-7 Cytosol, Endocytic vesicle
Nuclear Export Signal (NES)[33] 3-17 Nucleus, cytosol
Phosphotyrosine ligands bound by

Src Homology 2 (SH2) domains[34]

238-241 Cytosol
Class IV WW domain ligands[35] 343-348 Cytosol, nucleus
Cyclin-dependent kinase subunit 1 (Cks1) ligand[36] 344-349 Cytosol, nucleus
TNFR-associated factors 6

(TRAF6) binding site[37]

345-353 Cytosol
Peptide Amidation Site[38] 355-358 Extracellular, secretory granule
di-Arg retention/retrieving signal[39] 357-359 Endoplasmic reticulum membrane, ER-Golgi transport vesicle membrane, rough endoplasmic reticulum,

endoplasmic reticulum cisterna, cytosol, integral protein

N-arginine dibasic (NRD) cleavage site[40] 357-359 Extracellular, Golgi apparatus, cell surface
Src Homology 3 (SH3) ligand[41] 375-381 Plasma membrane, focal adhesion, cytosol
Glycosaminoglycan attachment site[42] 379-381 Extracellular, Golgi apparatus
STAT5 SH2 domain binding motif[43] 370-373

389-392

Cytosol
PDZ domain ligands[44] 423-428 Cytosol, internal side of plasma membrane
Pex14 ligand motif[45] 424-428 Cytosol, peroxisome, glycosome

Table 1. Results of ELM motif search after context, structural, and globular domain filtering with acceptable structural score (above medium threshold score).[22] There are 23 total identified post-translational modifications including phosphorylation sites in the human protein of ISLR.

Glycosylation Sites

Through the Simple Modular Architecture Research (SMART) tool[46] in Figure 3, an annotation predicted three N-linked glycosylation sites (red circles, starting from the left): 51 aa, 60 aa, and 309 aa. The LRR structural motifs and immunoglobulin C-2 type (IGc2) domain are shown in the diagram (Figure 3).

Figure 3. Predicted N-linked Glycosylation sites in SMART for human ISLR protein. The three PTMs are N-linked glycosylation (propagated, red circles).

Amidation Sites

Predicted with MyHits which investigates relationships between protein sequences and motifs,[47] an amidation site motif was confidently predicted at position 355-358 aa.

Palmitoylation sites

Three palmitoylation sites were predicted (Table 2).

Predicted Palmitoylation sites in CSS-Palm for the ISLR human protein
Position Peptide Score Cutoff
19 LLGLAQACPEPCDCG 21.194 3.717
23 AQACPEPCDCGEKYG 13.22 10.722
25 ACPEPCDCGEKYGFQ 4.463 3.717

Table 2. Results of the CSS-Palm[48] for the human protein of ISLR.

GPI-Modifications

Predicted with big-PI predictor,[49] one glucose phosphate isomerase (GPI) modification was found at position 401 aa (best site) with P-value score of 1.71e-03.[50]

Secondary and Tertiary Structure[edit]

Of all the predicted beta sheets, four stretches at 253-260 aa, 265-272 aa, 323-331 aa, and 335-346 aa were identified with high confidence using CFSSP[51] and Phyre2.[52] Of all the predicted alpha helices, three alpha helices at 5-15 aa, 189-195 aa, and 214-216 aa were identified with high confidence as well. A tertiary model of the human ISLR protein predicted by I-TASSER[53] shows a combination of some alpha helices and beta sheets (Figure 1). Based on the secondary structure prediction of the protein in I-TASSER, the locations of the four beta sheets and three alpha helices confirms the predictions of high confidence made by CFSSP and Phyre2.

Subcellular Localization[edit]

The ISLR protein in humans is expected to localize throughout a cell, including extracellular region, based on the predicted results of PSORT II.[54] The Reinhardt's method for cytoplasmic/nuclear discrimination predicted the protein to be more cytoplasmic with a reliability of 76.7. Additionally, ISLR was shown to localize in the cytoplasm based on the polyclonal antibody results in immunohistochemically stained human tissues in myocytes, glandular cells, skin, hepatocytes.[7] Immunofluorescent staining of ISLR in human cell line BJ (fibroblasts) showed localization to the plasma membrane using ISLR Polyclonal Antibody as well.[55]

Expression[edit]

In humans, RNA-seq was conducted on tissue samples from 95 individuals representing 27 different tissues to determine tissue-specificity of all protein-coding genes.[56] Notably, there is high expression of ISLR in endometrium and ovary and visible expression among 25 other tissues. Another study of RNA Sequencing of total RNA from 20 human tissues demonstrated high expression of ISLR in uterus.[57] Tissue-specific circular RNA induction during human fetal development showed steady expression of ISLR throughout the development with a high increase at 10 weeks for stomach.[58] Expression remained notably high to 20 weeks for stomach.

Figure 4. In situ Hybridization on Mouse Brain. Sagittal cut. IHC stained 5 for ISLR expression. Two raw expression values were found: (a) Olfactory areas with 3.18 and (b) Hippocampal formation with 1.10.

In the annotated figure, an in situ Hybridization on a 56-days old male mouse brain (sagittal cut) demonstrated expression in the olfactory areas and hippocampal formation (Figure 4).[59]

Based on Protein Abundance Database (PAXdb 4.1), the human protein of ISLR is shown with high protein abundance (ppm value > 1) relative to the whole organism.[60]

Expression in Clinical Studies[edit]

Expression profiling by microarray of ISLR in female human subjects demonstrated overexpression of ISLR in breast lipotransfer white adipose tissue CD34+ cells and significantly lower expression in leukapheresis CD34+ cells.[61]

Expression profiling by microarray of ISLR in human subjects demonstrated overexpression in non-union skeletal fractures compared to low expression in normal fractures.[62]

Expression profiling by microarray of ISLR in obese female human subjects demonstrated consistent low expression of ISLR in subjects that followed a short-term low-fat hypocaloric diet.[63]

Regulation of Expression[edit]

Gene level regulation[edit]

There is one promoter region in the ISLR gene with a predicted length of 1,912 bp (Figure 5) extracted from Genomatix.[64] Additionally, there is a polyadenylation signal at 3,142 bp in the ISLR nucleotide sequence (humans).[65]

There are six distinct transcription factors that bind onto the promoter region of ISLR from Genomatix predictions: two SMAD factors, sine oculis homeobox (SIX), heat shock factor (HSF), PRDM, Snail, and cell cycles gene homology region (CHR).[64]

Genomatix results predicted more transcription factor binding sites in ISLR with the highest matrix similarity (0.97~0.99) such as:

  1. Myeloid zinc finger 1 factor (MZF1)
  2. Nuclear factor of activated T-cells
  3. Hepatocyte nuclear factor 3 (alpha, beta) (FOXA1, FOXA2)
  4. E2F transcription factor 1
  5. Eomesodermin, TBR-2 (T-box, brain, 2) (Brachyury gene, mesoderm developmental factor)
  6. Homeodomain factor Nkx-2.5/Csx
  7. Estrogen-related receptor alpha (secondary DNA binding preference)
  8. Early B-cell factor 1 (Neuron specific olfactory factor)
  9. Nascent polypeptide-associated complex subunit alpha 1
  10. IKAROS family zinc finger 3 (Aiolos)
  11. 3' half site of ZTRE motif (zinc transcriptional regulatory element)
  12. AREB6 (Atp1a1 regulatory element binding factor 6)
Figure 5. Promoter Diagram of ISLR. The general locations of the exon 1, 2, and 3, the most confident promoter region, and UTRs were extracted from Genomatix.

Transcript level regulation[edit]

The human gene of ISLR is predicted to be targeted by 85 miRNAs in miRDB.[66] The top scoring (>88) miRNAs are has-miR-5197-3p, has-miR-4688, has-miR-3150a-3p, has-miR-16-5p, has-miR-195-5p, has-miR-15a-5p, and has-miR-6763-5p.

RBPmap,[67] which maps predicted binding sites of RNA binding proteins, showed multiple conserved motifs in evolution relative to the human ISLR mRNA transcript variant 1 sequence[13] such as:

  1. BRUNOL6
  2. CPEB2 and CPEB4
  3. ESRP2
  4. FMR1
  5. FUS
  6. FXR1 and FXR2
  7. G3BP2
  8. HNRNPA1, HNRNPA1L2, HNRNPA2B1, HNRNPC, HNRNPCL1, HNRNPF, HNRNPH1, HNRNPH2, HNRNPK, HNRNPL, HNRNPM, HNRNPU, HNRPLL.
  9. HuR
  10. IGF2BP2 and IGF2BP3
  11. KHDRBS2
  12. LIN28A

Homology and Evolutionary History[edit]

Paralogs[edit]

Currently, there is one other paralog in humans known as ISLR 2[68] and two paralogous domains: LRRN4 (protein precursor 4) and LRRN4CL (protein precursor 4 C-terminal like).[11]

Orthologs/Distant Homologs[edit]

As of August 2020, there above 190 known orthologs of the ISLR human gene,[69] the most distant ortholog and homolog found in Exaiptasia pallida (sea anemone).[70] The table below demonstrates the relationships between human ISLR protein characteristics and selected orthologs covering the range from closest related to Homo sapiens to most distant.

Orthologs of ISLR protein (human) Evolution Table
Species 1 Species 2 Common Name Taxonomic Group Accession number Date of Divergence Sequence Length Protein Percent Identity Protein Sequence Similarity
(Million years ago [MYA]) (aa)
Human vs. Homo sapiens Human Primates BAA85970.1 0 428 100% 100%
Human vs. Macaca fascicularis Crab-eating macaque Primates XP_005560108.1 29 428 98.33% 99.00%
Human vs. Tursiops truncatus Bottlenose dolphin Cetacea XP_033707870 96 428 91.58% 94.00%
Human vs. Mus musculus House mouse Rodentia BAA85973.1 160 428 88.24% 91.00%
Humans vs. Myotis brandtii Brandt's bat Therapsid XP_005882850.1 96 422 85.68% 89%
Human vs. Monodelphis domestica Gray short-tailed opossum Didelphimorphia XP_007478205     180 418 75.66% 83.00%
Human vs. Ornithorhynchus anatinus Platypus Monotremata XP_007663289.2 177 417 61.29% 72.00%
Human vs. Lacerta agilis Sand lizard Squamata XP_033016939.1 312 418 48.90% 58.00%
Human vs. Apteryx rowi Okarito kiwi Apterygiformes XP_025924151.1 318 429 48.03% 62.00%
Humans vs. Haliaeetus leucocephalus Bald eagle Accipitriformes XP_010569899   312 416 48.01% 61%
Human vs. Exaiptasia pallida Exaiptasia Actiniaria KXJ26782.1 824 304 29.89% 46.00%
Human vs. Bactrocera dorsalis Oriental fruit fly Diptera JAC38616.1 797 326 26.43% 48.00%
Human vs. Fopius arisanus Wasp (a parasitic type) Hymenopterans JAG75735.1 797 713 27.25% 42.00%

Interacting protein[edit]

Protein interactions[edit]

There are a total of 284 results from PSIQUIC View[71] of ISLR (human) that demonstrates its binding to numerous distinct proteins. iRefIndex showed 97 total results with multiple physical association interactions such as ISLR with Rho GTP-family (RHOBTB3), BMP7, Sphingose-1-Phosphate Lyase (SGPL1), Carnitine-acylcarnitine translocase (SLC25A20), Canopy FGF Signaling regulator 3 (CNPY3), and Leishmanolysin-like peptidase (LMLN).[72] The physical associations were identified with two hybrid pooling approach, affinity chromatography technology, enzymatic study, or anti-tag coimmunoprecipitation. Overall, the results from iRefIndex suggests ISLR to be involved in various mechanisms such as cell migration, transport of different complexes, and metabolism (enzymatic mechanisms). For example, RHOBTB3 is involved in transporting different complexes along pathways such as endosomes to trans Golgi network and Golgi to ER.[73] Furthermore, LMLN has been shown to play a role in cell migration, potentially mitotic progression.[74] In terms of metabolism, SGPL1 is involved in the metabolism of sphingolipids.[75]

Interactions with coronavirus strains[edit]

Based on the previous results from iRefindex[72] that indicated physical associations between ISLR and other proteins, two different interactions were identified with distinct strains of coronavirus. An interaction with orf1ab polyprotein of the human coronavirus strain HKU1(HCov-HKU1) was shown in physical association with ISLR through the two hybrid pooling approach, where ISLR is indicated as "prey" and the orf1ab polyprotein is indicated as "bait".[76]

There is another detected interaction of ISLR and Human SARS coronavirus through direct contact based on the two hybrid pooling approach.[76]

Clinical significance[edit]

Past studies[edit]

The delivery of ISLR-expressing lentivirus into a tumor stroma suppressed the growth of tumors in pancreatic ductal adenocarcinoma (PDAC).[77] In PDAC, low expression of ISLR (Meflin) was associated with aggressive tumors, characterized by straight collagen fibers in the stroma.[77] Regarding tumorigenesis in IBD patients, a study investigated the Hippo signaling pathway in intestinal regeneration of epithelial cells.[78] ETS1, an oncogenic transcription factor in stromal cells, induced the expression of ISLR protein which inhibited Hippo signaling, thus promoting intestinal regeneration.[78] In mice, it was demonstrated that deletion of ISLR in stromal cells can suppress tumorigenesis in the intestine.[78] For the ISLR 2 paralog, a study demonstrated that congenital hydrocephalus, arthrogryposis, and abdominal distension is associated with an autosomal recessive knockout on the phenotype of ISLR 2 in a multiplex consanguineous family.[79] ISLR 2 encodes a protein that plays a role in axon guidance in brain development, hence, unveiling potential links to certain congenital neurological disorders.[79]

References[edit]

  1. ^ a b c ENSG00000288508 GRCh38: Ensembl release 89: ENSG00000129009, ENSG00000288508 – Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000037206 – Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ a b c d e f g h "ISLR immunoglobulin superfamily containing leucine rich repeat [Homo sapiens (human)] - Gene - NCBI". www.ncbi.nlm.nih.gov. Archived from the original on 23 September 2020. Retrieved 2 August 2020.
  6. ^ "ISLR immunoglobulin superfamily containing leucine rich repeat [Homo sapiens (human)] - Gene - NCBI". www.ncbi.nlm.nih.gov. Archived from the original on 23 September 2020. Retrieved 2 August 2020.
  7. ^ a b "ISLR Primary Antibodies". www.thermofisher.com. Archived from the original on 23 September 2020. Retrieved 2 August 2020.
  8. ^ "ISLR Antibody (PA5-65263)". www.thermofisher.com. Archived from the original on 23 September 2020. Retrieved 2 August 2020.
  9. ^ Principe S, Jones EE, Kim Y, Sinha A, Nyalwidhe JO, Brooks J, et al. (May 2013). "In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine". Proteomics. 13 (10–11): 1667–1671. doi:10.1002/pmic.201200561. PMC 3773505. PMID 23533145.
  10. ^ a b Nagasawa A, Kubota R, Imamura Y, Nagamine K, Wang Y, Asakawa S, et al. (September 1997). "Cloning of the cDNA for a new member of the immunoglobulin superfamily (ISLR) containing leucine-rich repeat (LRR)". Genomics. 44 (3): 273–9. doi:10.1006/geno.1997.4889. PMID 9325048. Archived from the original on 23 September 2020. Retrieved 2 August 2020.
  11. ^ a b c "ISLR Gene - GeneCards | ISLR Protein | ISLR Antibody". www.genecards.org. Archived from the original on 17 September 2017. Retrieved 2 August 2020.
  12. ^ a b "AceView: Gene:ISLR, a comprehensive annotation of human, mouse and worm genes with mRNAs or ESTsAceView". www.ncbi.nlm.nih.gov. Archived from the original on 23 September 2020. Retrieved 2 August 2020.
  13. ^ a b c "Homo sapiens immunoglobulin superfamily containing leucine rich repeat (ISLR), transcript variant 1, mRNA". 4 July 2020. Archived from the original on 23 September 2020. Retrieved 2 August 2020. {{cite journal}}: Cite journal requires |journal= (help)
  14. ^ a b c "Homo sapiens immunoglobulin superfamily containing leucine rich repeat (ISLR), transcript variant 2, mRNA". 7 June 2020. Archived from the original on 23 September 2020. Retrieved 2 August 2020. {{cite journal}}: Cite journal requires |journal= (help)
  15. ^ "Homo sapiens immunoglobulin superfamily containing leucine rich repeat (ISLR), transcript variant 2, mRNA". 16 February 2019. Archived from the original on 23 September 2020. Retrieved 2 August 2020. {{cite journal}}: Cite journal requires |journal= (help)
  16. ^ "HGNC Symbol Report for ISLR". genenames.org. Archived from the original on 24 September 2019.
  17. ^ "ISLR [Homo sapiens] - Protein - NCBI". www.ncbi.nlm.nih.gov. Archived from the original on 23 September 2020. Retrieved 2 August 2020.
  18. ^ a b c d e "ISLR Protein Analysis SAPS tool". 27 July 2020. Archived from the original on 9 August 2020.
  19. ^ "Phobius". Archived from the original on 27 April 2019.
  20. ^ "SignalP-5.0". Archived from the original on 31 July 2020.
  21. ^ "NetPhos Prediction for BAA85970.1_ISLR (Homo sapiens)". 27 July 2020. Archived from the original on 23 September 2020.
  22. ^ a b "Eukaryotic Linear Motif (ELM) resource for Functional Sites in Proteins (BAA85970.1 ISLR_Human)".
  23. ^ "ELM - Detail for MOD_GSK3_1". elm.eu.org. Archived from the original on 29 January 2020. Retrieved 2 August 2020.
  24. ^ "ELM - Detail for MOD_PIKK_1". elm.eu.org. Archived from the original on 20 February 2020. Retrieved 2 August 2020.
  25. ^ "ELM - Detail for MOD_CK1_1". elm.eu.org. Archived from the original on 30 August 2020. Retrieved 2 August 2020.
  26. ^ "ELM - Detail for MOD_CK2_1". elm.eu.org. Archived from the original on 15 September 2020. Retrieved 2 August 2020.
  27. ^ "ELM - Detail for MOD_ProDKin_1". elm.eu.org. Archived from the original on 29 January 2020. Retrieved 2 August 2020.
  28. ^ "ELM - Detail for MOD_Plk_1". elm.eu.org. Archived from the original on 20 February 2020. Retrieved 2 August 2020.
  29. ^ "ELM - Detail for MOD_Plk_4". elm.eu.org. Archived from the original on 20 February 2020. Retrieved 2 August 2020.
  30. ^ "ELM - Detail for MOD_NEK2_1". elm.eu.org. Archived from the original on 20 February 2020. Retrieved 2 August 2020.
  31. ^ "ELM - Detail for DEG_Nend_UBRbox_3". elm.eu.org. Archived from the original on 20 February 2020. Retrieved 2 August 2020.
  32. ^ "ELM - Detail for TRG_LysEnd_APsAcLL_1". elm.eu.org. Archived from the original on 21 February 2020. Retrieved 2 August 2020.
  33. ^ "ELM - Detail for TRG_NES_CRM1_1". elm.eu.org. Archived from the original on 29 January 2020. Retrieved 2 August 2020.
  34. ^ "ELM - Detail for LIG_SH2_SRC". elm.eu.org. Archived from the original on 22 February 2020. Retrieved 2 August 2020.
  35. ^ "ELM - Detail for DOC_WW_Pin1_4". elm.eu.org. Archived from the original on 29 January 2020. Retrieved 2 August 2020.
  36. ^ "ELM - Detail for DOC_CKS1_1". elm.eu.org. Archived from the original on 20 February 2020. Retrieved 2 August 2020.
  37. ^ "ELM - Detail for LIG_TRAF6". elm.eu.org. Archived from the original on 22 February 2020. Retrieved 2 August 2020.
  38. ^ "ELM - Detail for MOD_Cter_Amidation". elm.eu.org. Archived from the original on 22 February 2020. Retrieved 2 August 2020.
  39. ^ "ELM - Detail for TRG_ER_diArg_1". elm.eu.org. Archived from the original on 22 February 2020. Retrieved 2 August 2020.
  40. ^ "ELM - Detail for CLV_NRD_NRD_1". elm.eu.org. Archived from the original on 22 February 2020. Retrieved 2 August 2020.
  41. ^ "ELM - Detail for LIG_SH3_3". elm.eu.org. Archived from the original on 30 January 2020. Retrieved 2 August 2020.
  42. ^ "ELM - Detail for MOD_GlcNHglycan". elm.eu.org. Archived from the original on 21 February 2020. Retrieved 2 August 2020.
  43. ^ "ELM - Detail for LIG_SH2_STAT5". elm.eu.org. Archived from the original on 22 February 2020. Retrieved 2 August 2020.
  44. ^ "ELM - Detail for LIG_PDZ_Class_1". elm.eu.org. Archived from the original on 20 February 2020. Retrieved 2 August 2020.
  45. ^ "ELM - Detail for LIG_Pex14_2". elm.eu.org. Archived from the original on 21 February 2020. Retrieved 2 August 2020.
  46. ^ "SMART: Main page". smart.embl-heidelberg.de. Archived from the original on 27 July 2020. Retrieved 2 August 2020.
  47. ^ "MyHits". myhits.sib.swiss. Archived from the original on 23 September 2020. Retrieved 2 August 2020.
  48. ^ "CSS-Palm - Palmitoylation Site Prediction". csspalm.biocuckoo.org. Archived from the original on 15 February 2009. Retrieved 2 August 2020.
  49. ^ "GPI Modification Site Prediction". mendel.imp.ac.at. Archived from the original on 21 July 2020. Retrieved 2 August 2020.
  50. ^ "big-PI Predictor of BAA85970.1_ISLR (Homo sapiens)". Archived from the original on 20 February 2018.
  51. ^ "CFSSP: Chou & Fasman Secondary Structure Prediction Server". www.biogem.org. Archived from the original on 9 August 2020. Retrieved 2 August 2020.
  52. ^ "PHYRE2 Protein Fold Recognition Server". www.sbg.bio.ic.ac.uk. Archived from the original on 11 August 2020. Retrieved 2 August 2020.
  53. ^ "I-TASSER server for protein structure and function prediction". zhanglab.ccmb.med.umich.edu. Archived from the original on 30 July 2020. Retrieved 2 August 2020.
  54. ^ "PSORT: Protein Subcellular Localization Prediction Tool". www.genscript.com. Archived from the original on 11 June 2020. Retrieved 2 August 2020.
  55. ^ "Polyclonal Antibody", Definitions, Qeios, 7 February 2020, doi:10.32388/lwiy89
  56. ^ Fagerberg L, Hallström BM, Oksvold P, Kampf C, Djureinovic D, Odeberg J, et al. (February 2014). "Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics". Molecular & Cellular Proteomics. 13 (2): 397–406. doi:10.1074/mcp.M113.035600. PMC 3916642. PMID 24309898.
  57. ^ Duff MO, Olson S, Wei X, Garrett SC, Osman A, Bolisetty M, et al. (May 2015). "Genome-wide identification of zero nucleotide recursive splicing in Drosophila". Nature. 521 (7552): 376–9. Bibcode:2015Natur.521..376D. doi:10.1038/nature14475. PMC 4529404. PMID 25970244.
  58. ^ Szabo L, Morey R, Palpant NJ, Wang PL, Afari N, Jiang C, et al. (June 2015). "Statistically based splicing detection reveals neural enrichment and tissue-specific induction of circular RNA during human fetal development". Genome Biology. 16 (1): 126. doi:10.1186/s13059-015-0690-5. PMC 4506483. PMID 26076956.
  59. ^ "Gene Detail :: Allen Brain Atlas: Mouse Brain". mouse.brain-map.org. Archived from the original on 23 September 2020. Retrieved 2 August 2020.
  60. ^ "PAXdb: Protein Abundance Database". pax-db.org. Archived from the original on 23 September 2020. Retrieved 2 August 2020.
  61. ^ Martin-Padura I, Gregato G, Marighetti P, Mancuso P, Calleri A, Corsini C, et al. (January 2012). "The white adipose tissue used in lipotransfer procedures is a rich reservoir of CD34+ progenitors able to promote cancer progression". Cancer Research. 72 (1): 325–34. doi:10.1158/0008-5472.CAN-11-1739. PMID 22052460.
  62. ^ "GEO DataSet Browser". www.ncbi.nlm.nih.gov. Archived from the original on 23 September 2020. Retrieved 2 August 2020.
  63. ^ Hietaniemi M, Jokela M, Rantala M, Ukkola O, Vuoristo JT, Ilves M, et al. (March 2009). "The effect of a short-term hypocaloric diet on liver gene expression and metabolic risk factors in obese women". Nutrition, Metabolism, and Cardiovascular Diseases. 19 (3): 177–83. doi:10.1016/j.numecd.2008.06.009. PMID 18804985. Archived from the original on 23 September 2020. Retrieved 2 August 2020.
  64. ^ a b "genomatix - Google Search". www.google.com. Archived from the original on 23 September 2020. Retrieved 3 August 2020.
  65. ^ "Homo sapiens chromosome 15, GRCh38.p13 Primary Assembly". 29 May 2020. Archived from the original on 5 October 2016. Retrieved 3 August 2020. {{cite journal}}: Cite journal requires |journal= (help)
  66. ^ "miRDB - MicroRNA Target Prediction Database". mirdb.org. Archived from the original on 6 August 2020. Retrieved 3 August 2020.
  67. ^ "RBPmap - Motifs Analysis and Prediction of RNA Binding Proteins". rbpmap.technion.ac.il. Archived from the original on 22 February 2020. Retrieved 3 August 2020.
  68. ^ "ISLR2 immunoglobulin superfamily containing leucine rich repeat 2 [Homo sapiens (human)] - Gene - NCBI". www.ncbi.nlm.nih.gov. Archived from the original on 23 September 2020. Retrieved 2 August 2020.
  69. ^ "ISLR orthologs". NCBI. Archived from the original on 23 September 2020. Retrieved 3 August 2020.
  70. ^ "LOC110239154 uncharacterized LOC110239154 [Exaiptasia diaphana] - Gene - NCBI". www.ncbi.nlm.nih.gov. Archived from the original on 23 September 2020. Retrieved 3 August 2020.
  71. ^ "PSICQUIC View". Archived from the original on 21 February 2020.
  72. ^ a b "PSICQUIC View for ISLR (Human)". www.ebi.ac.uk. Archived from the original on 23 September 2020. Retrieved 3 August 2020.
  73. ^ Espinosa EJ, Calero M, Sridevi K, Pfeffer SR (May 2009). "RhoBTB3: a Rho GTPase-family ATPase required for endosome to Golgi transport". Cell. 137 (5): 938–48. doi:10.1016/j.cell.2009.03.043. PMC 2801561. PMID 19490898.
  74. ^ "LMLN leishmanolysin like peptidase [Homo sapiens (human)] - Gene - NCBI". www.ncbi.nlm.nih.gov. Archived from the original on 7 December 2019. Retrieved 3 August 2020.
  75. ^ Taylor VA, Stone HK, Schuh MP, Zhao X, Setchell KD, Erkan E (December 2019). "Disarranged Sphingolipid Metabolism From Sphingosine-1-Phosphate Lyase Deficiency Leads to Congenital Nephrotic Syndrome". Kidney International Reports. 4 (12): 1763–1769. doi:10.1016/j.ekir.2019.07.018. PMC 6895586. PMID 31844815.
  76. ^ a b Pfefferle S, Schöpf J, Kögl M, Friedel CC, Müller MA, Carbajo-Lozoya J, et al. (October 2011). "The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors". PLOS Pathogens. 7 (10): e1002331. doi:10.1371/journal.ppat.1002331. PMC 3203193. PMID 22046132.
  77. ^ a b Mizutani Y, Kobayashi H, Iida T, Asai N, Masamune A, Hara A, et al. (October 2019). "Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis". Cancer Research. 79 (20): 5367–5381. doi:10.1158/0008-5472.CAN-19-0454. PMID 31439548.
  78. ^ a b c Xu J, Tang Y, Sheng X, Tian Y, Deng M, Du S, et al. (20 August 2019). Stromal ISLR promotes intestinal regeneration and cancer by suppressing epithelial Hippo signaling. Archived from the original on 23 September 2020. Retrieved 3 August 2020.
  79. ^ a b Alazami AM, Maddirevula S, Seidahmed MZ, Albhlal LA, Alkuraya FS (January 2019). "A novel ISLR2-linked autosomal recessive syndrome of congenital hydrocephalus, arthrogryposis and abdominal distension". Human Genetics. 138 (1): 105–107. doi:10.1007/s00439-018-1963-3. PMID 30483960. S2CID 53781275. Archived from the original on 23 September 2020. Retrieved 3 August 2020.
Retrieved from "https://en.wikipedia.org/w/index.php?title=ISLR&oldid=1215941113"